@ARTICLE{
author={Elsakov Pavel|,Foretova Lenka|,Goetz Petr|,de Groot Johannes WB|,van der Graaf Winette TA|,Guler Gulnur|,Huebner Kay|,Haites Neva E|,Hamann Ute|,Ho Judy|,Imyanitov Evgeny N|,Irmejs Arvids|,Purkalne Gunta|,Bitina Marianna|,Gardovskis Andris|,Gardovskis Janis|,Kirova Youlia M|,Fourquet Alain|,Pierga Jean-Yves|,Stoppa-Lyonnet Dominique|,Larizza Lidia|,Lips Cornelis JM|,Loman Niklas|,Borg Ake|,Moller Pal|,Olsson Hakan|,Park Jae-Gahb|,Radulovic Sinisa S|,Brankovic-Magic Mirjana V|0000-0001-8751-1281,Rajkumar Thangarajan|,Razis Evangelia|,Yannoukakos Drakoulis|,Schmitt Fernando|,Schmutzler Rita|,Simmonds Peter D|,Eccles Diana|,Smeltzer Jacob|,Silberstein Peter T|,Lynch Henry|,Weber Walter|,Willemse Pax HB|,Sijmons Rolf H|,Wysocki Piotr J|,Zajac Vladimir|,Shu Zheng|},
year={2007},
title={Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers},
journal={HEREDITY CANCER IN CLINICAL PRACTICE},
volume={5},
number={3},
pages={119-143},
document_type={Editorial Material},
}